Kekst and Company and Joele Frank, Wilkinsom Brimmer Katcher are advising Mallinckrodt's $5.6B acquisition of Questcor, announced today.
Kekst is bolstering PR for the Ireland-based acquirer, Mallinckrodt, where Meredith Fischer, senior VP, communications and PA, heads communications from its U.S. base in St. Louis.
Joele Frank, Wilkinson Brimmer Katcher is guiding M&A communications for Anaheim-based Questcor, the target of the $86.10-per-share deal.
Both boards have approved the deal, which is expected to close in the third quarter.
Questcor markets the $761.3M-a-yeaar H.P. Acthar gel for autoimmune and inflammatory conditions.
Mallinckrodt president/CEO Mark Trudeau said the deal diversifies his company's specialty pharmaceuticals portfolio, noting Questcor, along with recent acquisition Cadence Pharmaceuticals, gives Mallinckrodt an established presence with "prescribers, payers and hospitals."
No comments have been submitted for this story yet.